Summary of major recommendations for prevention of community respiratory virus infection.
| Type of Prevention . | Rating . |
|---|---|
| Abbreviations: HSCT, hematopoietic stem cell transplantation | |
| Prevention of Exposure | |
| Targeted surveillance system for respiratory viruses (virologic evaluation of HSCT candidates and recipients with upper respiratory symptoms) | AIII |
| Contact isolation of HSCT recipients and recipients with respiratory symptoms | AIII |
| Prevention of Disease or Disease Recurrence | |
| Influenza vaccination of HSCT recipients is not recommended < 6 months after transplant | AI |
| Type of Prevention . | Rating . |
|---|---|
| Abbreviations: HSCT, hematopoietic stem cell transplantation | |
| Prevention of Exposure | |
| Targeted surveillance system for respiratory viruses (virologic evaluation of HSCT candidates and recipients with upper respiratory symptoms) | AIII |
| Contact isolation of HSCT recipients and recipients with respiratory symptoms | AIII |
| Prevention of Disease or Disease Recurrence | |
| Influenza vaccination of HSCT recipients is not recommended < 6 months after transplant | AI |